Description
BLOOD PRODUCTS AND RELATED SERVICES
First action · last action
2017-10-23 · 2021-01-31
Transactions
2
First transaction's obligation
$517,326
Base + all options value (sum of deltas)
$428,657
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA26118D0215
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-23+$517,326= $517,326
- Mod P000012021-01-31-$88,669= $428,657
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-23 | +$517,326 | $517,326 | BLOOD PRODUCTS AND RELATED SERVICES |
| Mod P00001· FUNDING ONLY ACTION | 2021-01-31 | −$88,669 | $428,657 | BLOOD PRODUCTS AND RELATED SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GKT4L2JZJ622)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026D0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $0 | FY2026 |
| 36C26026N0391 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $70,000 | FY2026 |
| 36C24426N0344 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $1,682,246 | FY2026 |
| 36C24426D0025 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24426N0788 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $56,268 | FY2026 |
| 36C26126N0359 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $123,337 | FY2026 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26118J3273_3600_VA26118D0215_3600 · retrieved 2026-09-26.